Mark Devlin
Corporate Officer/Principal bij AMPLIA THERAPEUTICS LIMITED
Profiel
Mark Devlin is currently working as a Scientific Adviser at Amplia Therapeutics Ltd.
Previously, he held positions as the Chief Executive Officer at CTxONE, the Chief Operating Officer at Cancer Therapeutics CRC Pty Ltd., and an Associate Professor at Peter MacCallum Cancer Institute.
Dr. Devlin has an MBA from Melbourne Business School and a doctorate from the University of Melbourne.
Actieve functies van Mark Devlin
Bedrijven | Functie | Begin |
---|---|---|
AMPLIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Eerdere bekende functies van Mark Devlin
Bedrijven | Functie | Einde |
---|---|---|
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Chief Operating Officer | 01-09-2019 |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Corporate Officer/Principal | 01-09-2019 |
CTxONE | Chief Executive Officer | - |
Opleiding van Mark Devlin
Melbourne Business School | Masters Business Admin |
University of Melbourne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMPLIA THERAPEUTICS LIMITED | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Government |
CTxONE |